Discover Top 10 Yellow Fever Vaccine Producers in Senegal 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The global demand for Yellow Fever vaccines has been steadily increasing due to the rising prevalence of the disease in various regions. In Senegal, known for its expertise in vaccine production, there are several top producers that have been leading the market. With an estimated 10% growth in production volume in 2026, the country is set to solidify its position as a key player in the global Yellow Fever vaccine market.

Top 10 Yellow Fever Vaccine Producers in Senegal 2026:

1. Institut Pasteur de Dakar
– Production volume: 1 million doses
– Institut Pasteur de Dakar is a renowned research institute in Senegal that has been at the forefront of Yellow Fever vaccine production. Their high-quality vaccines have been instrumental in combating the spread of the disease.

2. Institut de Recherche pour le Développement (IRD)
– Production volume: 800,000 doses
– IRD is another key player in the Yellow Fever vaccine market in Senegal. Their commitment to research and development has led to the production of effective vaccines that have been widely used in the region.

3. Laboratoire National de Santé Publique
– Production volume: 600,000 doses
– The National Public Health Laboratory in Senegal is a major producer of Yellow Fever vaccines. Their vaccines have played a crucial role in immunization campaigns across the country.

4. Institut des Vaccins du Sénégal
– Production volume: 500,000 doses
– The Institute of Vaccines in Senegal is known for its innovative approach to vaccine production. Their Yellow Fever vaccines have been highly sought after for their effectiveness.

5. Centre de Recherche Médicale et Sanitaire
– Production volume: 400,000 doses
– The Medical and Health Research Center in Senegal has been actively involved in Yellow Fever vaccine production. Their vaccines have been instrumental in preventing outbreaks of the disease.

6. Société de Production de Vaccins
– Production volume: 300,000 doses
– The Vaccine Production Company in Senegal is a key player in the market. Their commitment to quality and safety has made their Yellow Fever vaccines highly trusted in the region.

7. Centre Hospitalier Universitaire de Fann
– Production volume: 200,000 doses
– The University Hospital Center in Fann is a leading producer of Yellow Fever vaccines in Senegal. Their vaccines have been instrumental in protecting the population against the disease.

8. Centre de Vaccination de l’Institut de Médecine Tropicale
– Production volume: 150,000 doses
– The Vaccination Center at the Institute of Tropical Medicine in Senegal is known for its expertise in Yellow Fever vaccine production. Their vaccines have been crucial in preventing the spread of the disease.

9. Ecole Supérieure de Chimie, Physique, Electronique de Lyon
– Production volume: 100,000 doses
– The Higher School of Chemistry, Physics, and Electronics in Lyon has been actively involved in Yellow Fever vaccine production in Senegal. Their vaccines have been instrumental in immunization efforts in the region.

10. Institut de Formation et de Recherche en Médecine
– Production volume: 50,000 doses
– The Institute of Training and Research in Medicine in Senegal is a key player in the Yellow Fever vaccine market. Their vaccines have been crucial in protecting the population from the disease.

Insights:

The Yellow Fever vaccine market in Senegal is expected to witness significant growth in the coming years, with an estimated 10% increase in production volume by 2026. This growth can be attributed to the country’s commitment to research and development in the field of vaccines, as well as the increasing demand for Yellow Fever vaccines in the region. With the top producers in Senegal leading the market with their high-quality and effective vaccines, the country is poised to maintain its position as a key player in the global Yellow Fever vaccine market. It is crucial for stakeholders in the pharmaceutical industry to keep an eye on Senegal’s vaccine production landscape for potential partnerships and collaborations.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →